Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

NYXH stock hub

Nyxoah SA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NYXHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

140.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NYXH

In the news

Latest news · NYXH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-111

P25 -106.6P50 -46.9P75 -3.1

ROIC-45.9

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NYXH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

EUR

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001857190
Company name	Nyxoah SA
Country	Belgium
Country code	US
Employees	153.7
Employees Change	-29.9%
Employees Change Percent	-16.29
Enterprise value	$133.3M
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2021-07-02
Isin	BE0974358906
Last refreshed	2026-05-10
Market cap	$140.3M
Market cap category	Micro-Cap
Price	$3.22
Price currency	USD
Rev Per Employee	76,543.31x
Sector	Healthcare
Sic	3841
Symbol	NYXH
Website	https://www.nyxoah.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-75.39%
EV Sales Forward	4.04x
EV/Sales	11.33x
FCF yield	-58.66%
P/B ratio	2.43x
P/S ratio	11.93x
PS Forward	4.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	63.13%
Gross Profit	$7.4M
Gross Profit Growth	113.07%
Gross Profit Growth Q	290.63%
Gross Profit Growth3 Y	48.44%
Gross Profit Growth5 Y	176.7%
Net Income	$-105.8M
Net Income Growth Years	0%
Pretax Margin	-888.98%
Profit Per Employee	$-688,164
ROA	-37.67
Roa5y	-21.78
ROCE	-120
ROE	-111
Roe5y	-50.46
ROIC	-45.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-49.15%
Cagr3y	-26.35%
EPS Growth Years	0
Revenue Growth	121.63x
Revenue Growth Q	346.87x
Revenue Growth Quarters	3x
Revenue Growth Years	5x
Revenue Growth3 Y	48.11x
Revenue Growth5 Y	170.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.07
Assets	$139.1M
Cash	$56.4M
Current Assets	$72.2M
Current Liabilities	$57.7M
Debt	$49.4M
Debt Equity	$0.86
Equity	$57.7M
Interest Coverage	-46.43
Liabilities	$81.4M
Long Term Assets	$66.9M
Long Term Liabilities	$23.7M
Net Cash	$7M
Net Cash By Market Cap	$4.96
Net Cash Growth	-90.58%
Net Debt Equity	$-0.12
Tangible Book Value	$57.2M
Tangible Book Value Per Share	$1.33
WACC	7.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.25
Inventory Turnover	0.79
Net Working Capital	$-14.1M
Quick ratio	1.14
Working Capital	$14.4M
Working Capital Turnover	$0.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.38%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-49.13%
200-day SMA	4.82
3Y total return	-60.06%
50-day SMA	3.23
50-day SMA vs 200-day SMA	50under200
All Time High	37
All Time High Change	-91.31%
All Time High Date	2021-08-06
All Time Low	2.76
All Time Low Change	16.49%
All Time Low Date	2026-03-30
ATR	0.17
Beta	0.88
Ch YTD	-30.11
High	3.26
High52	8.64
High52 Date	2025-05-22
High52ch	-62.79%
Low	3.12
Low52	2.76
Low52 Date	2026-03-30
Low52ch	16.49%
Ma50ch	-0.46%
Premarket Change Percent	3.13
Premarket Price	$3.3
Premarket Volume	10,600
Price vs 200-day SMA	-33.34%
RSI	54.64
RSI Monthly	34.63
RSI Weekly	36.92
Sharpe ratio	-0.81x
Sortino ratio	-1.08
Total Return	-16.38%
Tr YTD	-30.11
Tr1m	-2.58%
Tr1w	7.17%
Tr3m	-30.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$8
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.54
Earnings Revenue Estimate	7,130,000x
Earnings Revenue Estimate Growth	537.18x
Operating Income	$-98M
Operating margin	-832.8
Price target	$9.33
Price Target Change	$190
Price Target Change Top	$149

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24,490,502%
Float Percent	56.09%
Net Borrowing	24,986,968.8
Shares Insiders	18.53%
Shares Institutions	13.79%
Shares Out	43,662,403
Shares Qo Q	7.16%
Shares Yo Y	16.38%
Short Float	1.32%
Short Ratio	5.17
Short Shares	0.74

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-88M
Average Volume	29,598.3x
Bv Per Share	1.34
CAPEX	$-945,168
Ch1m	-2.58
Ch1w	7.17
Ch1y	-49.13
Ch3m	-30.86
Ch3y	-60.06
Ch6m	-34.61
Change	0.47%
Change From Open	-0.22
Close	3.2
Days Gap	0.69
Depreciation Amortization	1,283,076.4
Dollar Volume	212,894.1
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-98M
EBITDA	$-96.7M
EPS	$-2.78
F Score	3
FCF	$-82.3M
FCF EV Yield	-61.73x
FCF Per Share	$-1.88
Financing CF	44,742,280
Fiscal Year End	December
Founded	2,009
Income Tax	$1.2M
Investing CF	33,265,234
Ipr	-89.28
Iprfo	-89.29
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-26
Ma150	4.41
Ma150ch	-27.08%
Ma20	3.11
Ma20ch	3.51%
Net CF	-4,913,702
Next Earnings Date	2026-05-12
Open	3.22
Optionable	No
Position In Range	68.97
Post Close	3.22
Postmarket Change Percent	-0.47
Postmarket Price	$3.2
Ppne	6,303,348.5
Pre Close	3.2
Price Date	2026-05-08
Ptbv Ratio	2.45
Relative Volume	2.24x
Revenue	11,764,706x
SBC By Revenue	48.76x
Share Based Comp	5,736,762
Tax By Revenue	10.07x
Tr6m	-34.61%
Volume	66,219
Z Score	-3.6

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NYXH pay a dividend?

Capital-return profile for this ticker.

Performance

NYXH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NYXH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.8%

Float: +56.1% of shares outstanding

Insider ownership

+18.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NYXH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.6

Neutral momentum band

Price vs 200-day MA

-33.3%

50/200-day relationship not available

Beta (5Y)

0.88

Moves roughly with the market

Sharpe ratio

-0.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NYXH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NYXH stock rating?

Nyxoah SA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NYXH analysis?

The full report lives at /stocks/NYXH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NYXH?

The latest report frames NYXH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NYXH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.